Amanda Caroline da Silva/E+ via Getty Images
Investment Thesis
In our previous article, we discussed the bull thesis for GE HealthCare (NASDAQ:GEHC). The conclusion was that as an independent company, GEHC would have more room to grow and increase
GE HealthCare: Great Quarter, Upside Remains
Summary
- GE HealthCare's Q3 2023 financial results showed a 5% increase in revenue and a 90 basis point increase in gross margin.
- The company raised the low end of its Adj EPS guidance for 2023.
- GE HealthCare is facing challenges in China but is still performing better than competitors in the region, gaining market share.
- We remain bullish on the stock and reaffirm our $130 price target in 3 years.
Focused on growth stocks, catalyst-driven picks, and value gems. My methodology is rooted in the core fundamentals of the business, placing a strong emphasis on its capacity to generate cash and endure challenging economic conditions.
Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.